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ARTICLE CLASS OF EVIDENCE
Robot-assisted gait training to reduce pusher
behavior
A randomized controlled trial








To determine the effects of 2 weeks of intensive robot-assisted gait training (RAGT) on pusher
behavior compared to nonrobotic physiotherapy (nR-PT).
Methods
In a single-blind, randomized, controlled trial with 2 parallel arms, we compared 2 weeks of
daily RAGT (intervention group) with the same amount of nR-PT (control group). Patients
with subacute stroke who had pusher behavior according to the Scale for Contraversive Pushing
(SCP) were included. The primary research questions were whether changes in pusher be-
havior would differ between groups post intervention, and at a follow-up 2 weeks afterward
(SCP and Burke Lateropulsion Scale, Class II evidence). Secondary outcomes included the
Performance-OrientedMobility Assessment, the Functional Ambulation Classification, and the
Subjective Visual Vertical.
Results
Thirty-eight patients were randomized. Thereof, 30 patients received the allocated intervention
and were included in the analyses. RAGT led to a larger reduction of pusher behavior than nR-
PT at post test (SCP: U = 69.00, r = −0.33, p = 0.037; Burke Lateropulsion Scale: U = 47.500,
r = −0.50, p = 0.003) and at follow-up (SCP: U = 54.00, r = −0.44, p = 0.008). Pusher behavior
had ceased in 6 of 15 participants in the intervention group and 1 of 15 participants in the
control group at post test. At follow-up, 9 of 15 and 5 of 15 participants, respectively, no longer
exhibited the behavior.
Conclusions
Twoweeks of RAGT seems to persistently reduce pusher behavior, possibly by recalibrating the
disturbed inner reference of verticality. The potential benefits of RAGT on pusher behavior and
verticality perception require further investigation.
Trial registration
German Clinical Trials Register (registration number: DRKS00003444).
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Pusher behavior is a severe postural disorder exhibited by
some patients with stroke and reflects an altered perception
of body orientation in space.1–3 Patients with pusher be-
havior typically push themselves away from their non-
paretic body side and resist any attempt to transfer weight
over to the nonparetic side.4 The behavior affects 10% to
18% of patients in stroke rehabilitation and considerably
hampers the therapy and prolongs the rehabilitation
process.5–8 Such patients are only half as efficient and ef-
fective in their rehabilitation outcome compared to patients
with stroke without pusher behavior.8 Consequently, in-
novative treatment approaches that effectively reduce
pusher behavior are urgently needed.
So far, rehabilitation approaches for pusher behavior for the
most part focused on different forms of feedback training,
which means training of postural control strategies by using
visual cues, for example.9,10 However, evidence on the ef-
fectiveness of feedback training is insufficient, and patients
seem often unable to use the cues spontaneously. In a pilot
study, the immediate effects of a single session of physio-
therapy with visual feedback components, galvanic vestib-
ular stimulation, and robot-assisted gait training (RAGT)
were compared.11 After a session of RAGT, patients
showed a statistically significant reduction in pusher be-
havior compared to physiotherapy, while galvanic vestib-
ular stimulation did not cause any statistically significant
improvements. Forced control of upright body position
during locomotion seems to be an effective method for
immediately reducing pusher behavior.
The objective of this randomized controlled trial was to de-
termine the effects of 2 weeks of intensive RAGT on pusher
behavior in comparison to physiotherapy without robotic
support.
Methods
This was a single-blind, randomized, controlled trial with 2
parallel arms.
Standard protocol approvals, registrations,
and patient consents
The study was approved by the ethics committee of the
Ludwig-Maximilians University Munich. All participants or
their legal representatives gave their written informed con-
sent. This trial was registered at the German Clinical Trials
Register (DRKS00003444).
Participants
All participants included in the study were inpatients in a re-
habilitation setting at the Schön Klinik Bad Aibling. They met
the following inclusion criteria: hemiparesis after first unilat-
eral ischemic or hemorrhagic stroke, 3 weeks to 6 months
since onset, age between 18 and 90 years, pusher behavior
(Scale for Contraversive Pushing [SCP] >0 per component,
assessed by a physiotherapist and the study coordinator), and
orthostatic tolerance for 30 minutes of passive standing.
Patients with extreme osteoporosis, unstable fracture, or ex-
cessive spasticity were excluded from the study. Other ex-
clusion criteria were acute diseases of the cardiovascular or
respiratory system, and pressure sores on the lower extremi-
ties. Body weight was limited to 130 kg, body height to 200
cm, and the maximum leg length difference was 2 cm.
Because patients with pusher behavior frequently exhibit
cognitive deficits that may influence the recovery of pusher
behavior,12,13 the cognitive function was assessed at the be-
ginning of the study with the Addenbrooke’s Cognitive
Examination–Revised (ACE-R).14
Study protocol
Patients included in the study were randomly allocated to
either the intervention group (RAGT) or the control group
(nonrobotic physiotherapy [nR-PT]). The randomization
sequence was computer-generated with a ratio of 1:1 and
done by a scientific staff member not directly involved in the
project to ensure concealment. This staff member prepared
numbered and sealed opaque envelopes that were used by the
study coordinator to assign participants after study inclusion.
During the intervention phase, patients performed 8 to 10
sessions of the respective therapeutic intervention. The in-
tervention was planned to occur on 5 days per week for 2
weeks. If a patient was not able to finish all sessions as plan-
ned, up to 2 additional sessions were scheduled in the fol-
lowing week in order to have values from at least 8 sessions for
each patient. Primary and secondary outcome measures were
assessed before the intervention phase (baseline), at the end
of the 2-week intervention phase (post test), and at a follow-
up test 2 weeks after the end of the intervention phase. During
the follow-up phase, no RAGT or treadmill training was
performed until the follow-up test.
Interventions
Patients of the intervention group received RAGT on the
robotic-driven gait orthosis Lokomat (Hocoma AG, Vol-
ketswil, Switzerland). A RAGT session lasted 60minutes. The
Glossary
ACE-R = Addenbrooke’s Cognitive Examination–Revised; BLS = Burke Lateropulsion Scale; FAC = Functional Ambulation
Classification; nR-PT = nonrobotic physiotherapy; POMA = Performance-Oriented Mobility Assessment; POMA-B =
Performance-Oriented Mobility Assessment–balance items; RAGT = robot-assisted gait training; SCP = Scale for
Contraversive Pushing; SVV = Subjective Visual Vertical.
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Lokomat is an exoskeleton with linear drives on hip and knee
joints that assist locomotion on a treadmill by guiding the
participant’s legs along a predefined trajectory. Patients are
connected to the gait orthosis by a harness, which is attached
to a body-weight support system, and by cuffs placed around
the legs. Elastic straps are used to passively lift the participant’s
feet and prevent foot drop. Body weight support was in-
dividually set for each patient, but amounted to no more than
50% of the patient’s body weight. Guidance force was set at
100% on both sides. After a short warming-up period, walking
speed was increased to 2 km/h or faster. The target walking
time was at least 20 minutes.
Patients of the control group received nR-PT. A session of nR-
PT was scheduled for 60 minutes, either 2 × 30 minutes or 1 ×
30minutes with cotherapy (2 therapists; the target was at least
20 minutes of active therapy). The focus of nR-PT was on
training of postural control including sensory feedback com-
ponents. The therapy consisted only of active and dynamic
exercises, such as shifting of the center of gravity; no passive or
static exercises were planned. Therapists and patients were
allowed to use external references, such as a wall or a handrail
on the nonparetic side, and visual feedback, such as the door
frame or a mirror. The training was performed while sitting or
standing; movement transitions, such as transferring from
sitting to standing, and walking if possible, were practiced.
Content and characteristics of each therapy session were
documented for both interventions in standardized protocols.
Primary outcome measures
The primary objective of the study was to determine the
effects of RAGT on pusher behavior. Pusher behavior was
assessed by using the SCP and the Burke Lateropulsion Scale
(BLS). In the preceding pilot study, only the BLS showed
statistically significant effects of RAGT.11 However, by the
time the present study was designed, the SCP was the most
frequently used and investigated scale for pusher behavior,
while the BLS was seldom evaluated. That is why we decided
to use both scales as primary outcome measures. The scales
were assessed at baseline, at post test, and at a follow-up test 2
weeks after the end of the intervention phase by a trained
assessor who was blinded to treatment allocation.
The SCP has 3 components: (1) the symmetry of sponta-
neous body posture, (2) the use of nonparetic extremities (leg
and arm), and (3) the resistance to passive correction of the
tilted posture.2 Each component is tested in sitting and
standing positions, yielding a maximum score of 2 per com-
ponent (1 for sitting and 1 for standing). The total score of the
SCP ranges from 0 to 6. The SCP has a high interobserver
reliability and internal consistency, and a moderate to high
construct validity.7,15 For the diagnosis of pusher behavior,
a cutoff score >0 was used for each component.7
The BLS rates the patient’s resistance to passive supine roll-
ing, to passive postural correction when sitting and standing,
and to assistance during transferring and walking. The greater
the resistance, the higher the score.16 The maximal score of
the BLS is 17. The cutoff for the diagnosis of pusher behavior
is ≥2 points.17 The BLS shows a high interrater and intrarater
reliability.16
Secondary outcome measures
Secondary outcome measures were the balance items of the
Performance-Oriented Mobility Assessment (POMA-B), the
Functional Ambulation Classification (FAC), and the Sub-
jective Visual Vertical (SVV). The measures were assessed at
baseline, at post test, and at a follow-up test 2 weeks after the
end of the intervention phase by a trained assessor who was
blinded to treatment allocation.
The POMA-B evaluates balance.18 It tests different positions
and changes in positions, reflecting stability tasks that are
related to daily activities. The POMA-B shows high interrater
and intrarater reliability and satisfactory concurrent and dis-
criminant validity.
The FAC rates walking ability. It distinguishes 6 levels of
walking ability on the basis of the amount of physical support
required.19 Categories range from 0 (patient cannot walk or
needs help from 2 or more persons) to 5 (patient can walk
independently anywhere). The FAC has high reliability, good
concurrent and predictive validity, and good responsiveness.20
The SVV measures a person’s perception of visual verticality.
The so-called bucket test was used for SVV assessment.21 The
bucket was rotated by the examiner, and the seated partic-
ipants indicated when they visually perceived a dark line to be
vertical. Six trials were performed in the frontal plane. Results
of these trials were averaged to obtain the SVV.
Statistical analysis
The primary hypothesis was that patients assigned to RAGT
would have a larger improvement in pusher behavior (SCP
and BLS) than patients assigned to nR-PT after the 2-week
intervention phase and at a follow-up (Class II evidence).
An a priori sample-size calculation was performed using the
method derived by Noether.22 Effect size was estimated based
on the data of the previous pilot study resulting in pNoether =
0.8 for the BLS.11,23 Assuming this effect size with a 2-sided
significance level of 0.05% and 80% power, sample-size cal-
culation resulted in a sample size of 15 patients per group. To
account for an anticipated dropout rate of 25%, the minimum
number of patients required to enroll per group was increased
to 38 patients for the entire study.
Demographic and clinical characteristics of patients were
compared between the intervention and the control groups
using the χ2 test (for comparison of proportions) or Student t
test (for continuous variables). Kendall tau statistics was used
to investigate the relationship between the ACE-R score and
patients’ response to the interventions.
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Data of all patients who received at least one session of the
allocated intervention were included in the analyses. Missing
outcome values were replaced using the last-observation-
carried-forward method.
Nonparametric statistics were used for all outcome variables
because of the ordinal scale quality of the measures (SCP,
BLS, POMA, FAC), or in case of abnormally distributed data
(SVV). Between-group comparisons (intervention vs control
group) for the primary and secondary outcome measures
were performed for the baseline values, and for the intra-
individual differences calculated from baseline to post (short-
term effect) and from baseline to follow-up (long-term effect)
using Mann-Whitney U tests. In addition, within-group
comparisons were performed using Friedman tests. If the
Friedman test showed statistically significant differences,
Wilcoxon matched-pairs tests were performed to compare
baseline and post, and baseline and follow-upmeasures. Effect
sizes (r) of changes between groups and within-groups were
calculated.24 Effect size of 0.1, 0.3, and 0.5 represents a small,
medium, and large effect, respectively.25
The statistical analyses were performed using SPSS Statistics
(version 19.0; IBM Corp., Armonk, NY). The significance
level for α was set at 0.05.
Classification of evidence
This study provides Class II evidence that 2 weeks of intensive
RAGT reduces pusher behavior (SCP and BLS) in patients
with stroke compared to the same amount of nR-PT.
Data availability
Datasets generated and analyzed during the current study are
available in an anonymized form from the corresponding
author on reasonable request.
Figure Participant flow diagram
PB = pusher behavior.
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Results
Thirty-eight patients were enrolled in the study between
December 2011 and July 2016. The final follow-up test was
made in August 2016. A flow diagram shows how patients
progressed through the study, including reasons for dropping
out or data lost (figure). A total of 30 patients received the
allocated intervention and were included in the analysis.
There were no statistically significant differences between the
intervention and the control groups for any of the de-
mographic or clinical characteristics at the beginning of the
intervention (table 1). Two patients in the intervention group
and 6 patients in the control group were not able to complete
the ACE-R because of severe cognitive or language deficits.
There was no correlation between the ACE-R scores and the
changes in pusher behavior over the study period (tau ≤
−0.095; p ≥ 0.5).
Characteristics of the therapies, such as the number of per-
formed therapies, actual walking or therapy time, etc., can be
found in table 2.
Primary outcome measures
At baseline, there were no significant differences between
groups for the SCP and the BLS (SCP: U = 105.00, r = −0.06,
p = 0.775; BLS: U = 99.00, r = −0.10, p = 0.595). Short-term
(baseline − post) and long-term (baseline − follow-up)
changes in the primary outcome measures are shown in table
3. The SCP revealed a significantly larger short-term effect
and long-term effect in the intervention than in the control
group. With the BLS, only the short-term effect significantly
differed between groups (U = 47.50, r = −0.50, p = 0.003), but
the long-term effect did not reach significance (U = 76.50, r =
−0.28, p = 0.069).
Table 4 shows group values for all outcomemeasures including
within-group comparisons. Both groups significantly improved
pusher behavior during the study period. Wilcoxon tests
revealed for the intervention group a significant improvement
from baseline to post test measured with the BLS (Z = −3.305,
r = −0.85, p = 0.001), and significant improvement from
baseline to follow-up test measured with the SCP (Z = −2.534,
r = −0.65, p = 0.012) and the BLS (Z = −3.248, r = −0.84, p =
0.001). For the control group, a significant improvement was
only found from baseline to follow-up test measured with the
SCP (Z = −2.524, r = −0.65, p = 0.012) and the BLS (Z =
−2.598, r = −0.67, p = 0.009).
Table 1 Demographics and baseline clinical characteristics of the intervention group (RAGT) and the control
group (nR-PT)
RAGT (n = 15) nR-PT (n = 15) Between-group comparisons
Age, mean ± SD, y 72 ± 9 71 ± 10 t28 = −0.500, p = 0.621
Sex, F/M 5/10 8/7 Χ21 = 1.222, p = 0.269
Ischemic/hemorrhagic stroke 8/7 9/6 Χ21 = 0.136, p = 0.713
Side of lesion, R/L 11/4 12/3 Χ21 = 0.186, p = 0.666
Time since stroke, mean ± SD, wk 7.5 ± 2.6 8.0 ± 3.8 t28 = −0.436, p = 0.666
ACE-R, median (Q1–Q3) 66 (51–76) (n = 13) 57 (39–64) (n = 9) U = 34.000, Z = −1.639, p = 0.110
Abbreviations: ACE-R = Addenbrooke’s Cognitive Examination–Revised; nR-PT = nonrobotic physiotherapy; Q1 = first quartile; Q3 = third quartile; RAGT =
robot-assisted gait training.
Table 2 Characteristics of the therapeutic interventions




RAGT (n = 15)
No. of therapy sessions 8.1 ± 2.6 (1–10)
Walking time, min 19.2 ± 6.0 (3–26)
Walking speed, km/h 2.1 ± 0.4 (1.1–2.7)
Body weight support (% body weight) 38.6 ± 18.0
(5.6–57.5)
nR-PT (n = 15)
No. of therapy sessions 9.7 ± 0.5 (9–10)
Active therapy time per session, min 32 ± 14 (16–58)
Sitting, min/session 10 ± 7 (0–24)
Sitting to standing, min/session 6 ± 4 (1–16)
Transferring, min/session 6 ± 3 (2–14)
Standing, min/session 11 ± 7 (3–23)
No. of sessions in which external references
were used
7.2 ± 1.9 (4–10)
No. of sessions with cotherapy (2 therapists) 3.3 ± 1.8 (1–6)
Abbreviations: RAGT = robot-assisted gait training; min–max = minimum–
maximum; nR-PT = nonrobotic physiotherapy.
Values were first averaged for the individual patient and then for the group.
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The number of patients not showing pusher behavior
according to the SCP at post test significantly differed be-
tween the groups (χ21 = 4.658, p = 0.031): The behavior
ceased in 6 of 15 patients (40.0%) in the intervention group
and in 1 of 15 patients (6.7%) of the control group during the
intervention phase. At follow-up test, 9 of 15 patients (60.0%)
in the intervention group and 5 of 15 patients (33.4%) in the
control group showed no pusher behavior (χ21 = 2.143, p =
0.143).
Secondary outcome measures
Group values and within-group comparisons for the POMA,
the FAC, and the SVV are shown in table 4. There were no
significant differences between groups for the POMA and the
FAC at baseline (POMA: U = 109.500, Z = −0.145, r = −0.03,
p = 0.902; FAC:U = 105.00, Z = −1.000, r = −0.18, p = 0.775).
The intervention group showed a significantly larger long-
term effect with the POMA than the control group (U =
72.000, Z = −1.802, r = −0.33, p = 0.049). The short-term
effect was similar between groups (U = 99.000, Z = −0.803, r =
−0.15, p = 0.298). Changes in the FAC did not differ between
the groups (short-term effect:U = 112.00, Z = 0.000, r = −0.00,
p = 0.500; long-term effect:U = 102.00, Z = −0.590, r = −0.11,
p = 0.342). Only 9 patients of the intervention group and 8
patients of the control group were able to perform SVV as-
sessment. Neither the SVV at baseline (U = 25.000,Z = −1.060,
r = −0.26, p = 0.321) nor the SVV changes significantly differed
between the groups (U = 29.000, Z = −0.682, r = −0.17, p =
0.541; U = 35.000, Z = −0.096, r = −0.02, p = 0.963).
Discussion
The present study investigated the effectiveness of repeated
RAGT on pusher behavior. Our results indicate that 2
weeks of intensive RAGT leads to a statistically significant
reduction of pusher behavior compared to nR-PT. The
beneficial effect of RAGT persisted 2 weeks after the end of
the intervention phase when using the SCP. RAGT led not
only to a larger improvement of pusher behavior, but also to
a larger number of patients whose pusher behavior ceased
completely. Forty percent and 60% of patients of the in-
tervention group showed no more pusher behavior after the
intervention phase and at the follow-up, respectively. In
contrast, 7% and 33% of patients of the control group
recovered from pusher behavior at the respective time
points. Recovery of pusher behavior is very relevant for the
treatment and outcome of these patients. The longer
pusher behavior persists, the worse is the rehabilitation
outcome.8 However, a reduction of the behavior also seems
important, as the severity of pusher behavior correlates
with the deviation of the inner reference of verticality and
with the impairment of balance performance.1,26 Conse-
quently, improvements in pusher behavior might facilitate
the mobilization and treatment of patients. Similar to this,
we found a statistically significant larger improvement of
balance performance in the intervention group than in the
control group at follow-up testing. No differences between
groups were found for the FAC and SVV. In both groups,
SVV was within the ranges of normality (−2.5° to 2.5°)3 at
baseline testing and remained within this range over the
study period. The FAC, by contrast, resulted in floor effects
in our study sample, as gait is usually not possible for
patients with pusher behavior, except in very mild pusher
behavior. Although the intervention group practiced gait
and the control group mainly postural control, walking
abilities remained very limited in both groups.
RAGT is an active and task-oriented treatment approach in
which the patient’s body is in an earth vertical position, as
suggested previously for patients with pusher behavior.4 The
harness system and the firm connection to the robot might
lessen the patient’s fear of falling and it secures and supports
the patient in an upright standing position.27 This allows
training in an upright body position for a prolonged period of
time. In the present study, patients spent on average 19
minutes per session walking in the gait trainer. When adding
the time for pre- and postprocessing (attachment and removal
of the harness and the cuffs) and for possible breaks, patients
of the intervention group spent approximately 30 to 40
minutes per session in an upright standing position. Accord-
ing to the therapy protocols, patients of the control group
trained on average only 11 minutes per session in a standing
position.
We suggest that not only the upright body orientation but
especially locomotion in that position are beneficial to treat
pusher behavior. RAGT allows patients to practice weight
loading and unloading of the lower extremities. The patient
Table 3 Median change (Q1–Q3) in primary outcome measures from baseline
Difference, baseline 2 post Difference, baseline 2 follow-up
RAGT (n = 15) nR-PT (n = 15)
Between-group
comparison RAGT (n = 15) nR-PT (n = 15)
Between-group
comparison








U = 54.00, r = −0.44, p = 0.008
BLS −4 (−6 to −1) 0 (−2 to –1) U = 47.50, r = −0.50, p = 0.003 −4 (−6 to −3) −3 (−5 to −1) U = 76.50, r = −0.28, p = 0.069
Abbreviations: BLS = Burke Lateropulsion Scale; nR-PT = nonrobotic physiotherapy; Q1 = first quartile; Q3 = third quartile; RAGT = robot-assisted gait training;
SCP = Scale for Contraversive Pushing.
e1324 Neurology | Volume 91, Number 14 | October 2, 2018 Neurology.org/N
Copyright ª 2018 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
can learn to place weight on the paretic limb and simulta-
neously move the nonparetic leg in a rhythmic pattern while
maintaining an upright body position.4,13 The guided walking
pattern also induces a stereotyped somatosensory cueing and
an increased somatosensory stimulation, which might im-
prove the altered internal reference of verticality.1,28,29
In addition, patients must deal with conflicting sensory in-
formation during RAGT. While the proprioceptive inputs
from the lower extremities mimic an appropriate stepping
pattern on a moving support surface, the vestibular and visual
inputs do not imply forward movement in space. Conflicting
sensory information may lead to a continuous reweighting of
the sensory input. This training of the central sensory in-
formation processing might help to improve the impaired
body orientation in space and postural stability.30 It must still
be determined which of the discussed factors are relevant, also
whether alone or in combination, for the improvement of
pusher behavior. It would be interesting to compare RAGT
with body-weight-supported gait training on the treadmill or
on the ground. So far, gait training is not a common approach
in the treatment of pusher behavior, because these patients
have a severely impaired postural control, and improvement
of gait is rarely a therapeutic objective. However, this study
showed that RAGT also affects pusher behavior and postural
control.
Another advantage of RAGT might be that its effects on
pusher behavior are based on a mostly implicit learning pro-
cess while other therapeutic approaches, such as physiother-
apy with visual feedback training, are based on an explicit
learning process. Explicit motor learning involves cognitive
stages within the learning process and is dependent on
working memory involvement, while implicit learning
requires no or only minimal conscious involvement and only
minimally loads working memory.31 During visual feedback
training, the patient is instructed to visually explore the sur-
rounding and has to recognize and understand the mismatch
between their perceived and their actual body orientation.
After the patient realizes their tilted posture, they have to learn
postural reactions to align their body with the “true vertical,”
i.e., the vertical visual cues.9 Finally, the patient has to au-
tomatize this strategy and transfer it into everyday situations.
Because patients with pusher behavior often show severe
cognitive impairments,12,13 the visual feedback therapy might
be unfeasible for many of them. In addition, it is based on an
unimpaired perception of the visual vertical. There is no
specific bias of the SVV in patients with pusher behavior, but
they show a higher threshold in visual verticality perception
than patients with stroke who do not have pusher behavior.32
So far, evidence on the effectiveness of visual feedback
training in patients with pusher behavior is insufficient.9–11
In the present study, we used 2 different scales to evaluate
pusher behavior, namely, the SCP and the BLS. Both scales
revealed a larger reduction of pusher behavior after 2 weeks of
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pusher behavior further improved according to the SCP, but
only slightly changed on the BLS. This is surprising since the
BLS is considered to be more sensitive than the SCP in
detecting changes in pusher behavior.17,33 Our data revealed
some incongruences between the scales and the measure-
ments mainly for the items rating resistance during sitting and
the supine item of the BLS. Previously, researchers reported
certain difficulties in detecting small body tilts or determining
the degree of tilt using the BLS, and some differences between
the rating of spontaneous body posture on the SCP and the
actual body posture assessed with photography.26,33 Although
the investigators of the present study were experienced and
trained in the use of the scales, problems in the assessment
might possibly explain the incongruences.
Our study had certain limitations regarding the generalization
of the results. Most of the exclusion criteria of the present
study, such as orthostatic intolerance or acute cardiovascular
disease, were contraindications for the training with the
Lokomat defined by the company. While training with the
device is restricted to a certain patient population because of
these contradictions, nR-PT can be used with almost any
patient. Dependent on the severity of pusher behavior and the
therapy content, cotherapy (2 therapists) might facilitate nR-
PT. We found cotherapies most frequently in patients with
moderate to severe pusher behavior (SCP scores >3). For
several patients of the intervention group, it was not possible
to comply with the therapy protocol (e.g., failure of therapy
session or less than the targeted walking time). This implies
that the intensive therapy setting used in the present study
might not always be feasible. Future research should de-
termine whether a less intensive setting has similar effects. In
addition, a longer intervention phase might lead to a better
outcome and possibly to improved long-term effects. The
long-term effect in this study was calculated as the difference
between baseline and follow-up test. Because the follow-up
period lasted only 2 weeks, the so-called long-term effect has
to be interpreted with caution. A longer follow-up period
would result in more valid results about the long-term effects
of RAGT and nR-PT.
All patients included in this study showed cognitive deficits
with ACE-R scores <84 (age-dependent normal range
84–100).14 Several patients had severe cognitive deficits and 8
patients were not able to do the cognitive examination. Even
though we found no correlation between the ACE-R score
and the improvement of pusher behavior, these deficits might
have influenced the patients’ response to the interventions.
This applies in particular to the control group in which the
deficits were more pronounced and the intervention involved
more explicit learning processes. The 3 patients of the in-
tervention group who did not complete the study per protocol
had relatively high ACE-R scores (73–79). We did not apply
the cognitive deficits as an exclusion or a stratification crite-
rion. In future studies, it is advised to control more thoroughly
for cognitive function and its influence on patients’ adherence
and response to treatment.
Finally, the “natural” recovery has to be considered. A pre-
vious study showed that the recovery of pusher behavior
varies widely among patients: approximately half of the
patients identified with pusher behavior at rehabilitation ad-
mission exhibited the behavior less than 4 weeks during their
rehabilitation stay, while others showed very persistent pusher
behavior.8 A delayed recovery of pusher behavior seems to be
associated with age and severe stroke impairments.12 In the
present study, the average time between stroke onset and
study inclusion was about 8 weeks in both groups (minimum
3 weeks), and demographic characteristics did not show any
differences between groups. Future intervention trials should
consider prognostic factors in their study design and mainly
target patients with risk factors for developing persistent
pusher behavior in order to ameliorate their rehabilitation
outcome.
Two weeks of RAGT seems to persistently reduce pusher
behavior. The forced upright body position during loco-
motion and the somatosensory stimulation might recali-
brate the disturbed inner reference of verticality in patients
with pusher behavior. Previous work showed that these
patients require prolonged rehabilitation.5,8 Consequently,
efficient approaches are needed to improve their re-
habilitation. Our results suggest that the recovery process is
more efficient when RAGT is applied.
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